Your ADSRCM 2025 Year-End Lab Revenue Briefing A Message from Jim: As 2025 draws to a close, it’s clear this has been one of the most financially complex and operationally demanding years the lab industry has seen in over a decade. From payer price compression to the ongoing PAMA uncertainty, mounting denial volumes, and compliance burdens, labs are being pushed to rethink their revenue strategies—and fast. At ADSRCM, our job is to help you make sense of these challenges, find the missed revenue, and build sustainable billing infrastructure that actually works in today’s landscape.